Hillstream BioPharma, Inc.
HILS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,102 | -$1,855 | -$2,542 | -$5,352 |
| Dep. & Amort. | $25 | $25 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $527 | $559 | $219 | $49 |
| Change in WC | $221 | $366 | $0 | -$49 |
| Other Non-Cash | -$527 | -$238 | -$366 | $335 |
| Operating Cash Flow | -$1,855 | -$1,143 | -$2,689 | -$5,017 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $958 | $2,500 | $0 | $1,840 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7,224 | $2,309 | $206 | $1,463 |
| Financing Cash Flow | $7,224 | $2,309 | $206 | $1,463 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5,368 | $1,166 | -$2,483 | $870 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,242 | $1,076 | $3,559 | $2,689 |
| End Cash | $7,610 | $2,242 | $1,076 | $3,559 |
| Free Cash Flow | -$1,855 | -$1,143 | -$2,689 | -$5,017 |